Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Harvard Bioscience (NQ: HBIO ) 2.880 -0.050 (-1.71%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Harvard Bioscience < Previous 1 2 3 Next > HBIO Stock Earnings: Harvard Bioscience Misses Revenue for Q2 2024 August 08, 2024 HBIO stock results show that Harvard Bioscience missed on revenue for the second quarter of 2024. Via InvestorPlace Harvard Bioscience Announces Second Quarter 2024 Financial Results August 08, 2024 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET August 02, 2024 From Harvard Bioscience, Inc. Via GlobeNewswire Holley And 2 Other Stocks Under $5 Insiders Are Buying June 17, 2024 Via Benzinga FlexShopper And 3 Other Stocks Under $5 Insiders Are Buying June 10, 2024 Via Benzinga A Preview Of Harvard Bioscience's Earnings March 06, 2024 Via Benzinga Earnings Preview For Harvard Bioscience November 06, 2023 Via Benzinga Preview: Harvard Bioscience's Earnings August 07, 2023 Via Benzinga Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024 June 06, 2024 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024 May 23, 2024 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference May 16, 2024 From Harvard Bioscience, Inc. Via GlobeNewswire HBIO Stock Earnings: Harvard Bioscience Meets EPS, Misses Revenue for Q1 2024 May 07, 2024 HBIO stock results show that Harvard Bioscience met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Harvard Bioscience Announces First Quarter 2024 Financial Results May 07, 2024 Strong gross margin performance and focus on efficiency to support ongoing investments in growth From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET April 29, 2024 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth April 09, 2024 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference March 11, 2024 From Harvard Bioscience, Inc. Via GlobeNewswire HBIO Stock Earnings: Harvard Bioscience Misses EPS, Misses Revenue for Q4 2023 March 07, 2024 HBIO stock results show that Harvard Bioscience missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. Via InvestorPlace Harvard Bioscience Announces Fourth Quarter 2023 Financial Results March 07, 2024 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting March 06, 2024 Solutions for CROs, pharma and biotechs improve throughput and efficiency and enable future advancements in data analytics From Harvard Bioscience, Inc. Via GlobeNewswire Earnings Scheduled For March 7, 2024 March 07, 2024 Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. Via Benzinga Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET February 27, 2024 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023 November 20, 2023 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023 November 09, 2023 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience Announces Third Quarter 2023 Financial Results November 07, 2023 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023 November 06, 2023 Innovative solutions for academic, CRO, pharma and biotech customers From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET October 30, 2023 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research September 18, 2023 From Harvard Bioscience, Inc.; Etisense Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session August 30, 2023 Via Benzinga Harvard Bioscience Announces Second Quarter 2023 Financial Results August 08, 2023 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023 August 03, 2023 From Harvard Bioscience, Inc. Via GlobeNewswire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.